Compare ARK Genomic Revolution ETF (ARKG) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Cassava Sciences Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | FLNA | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $44.55 | $4.64 |
52-Week Low | $24.02 | $0.87 |
Market Cap | — | $47.75M |
Enterprise Value | — | -$34.93M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
